Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP522512.RApbGFfkTiUTW7n4zqZmFbTvu6kLHAjh58qf1G1_S1k80130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP522512.RApbGFfkTiUTW7n4zqZmFbTvu6kLHAjh58qf1G1_S1k80130_assertion type Assertion NP522512.RApbGFfkTiUTW7n4zqZmFbTvu6kLHAjh58qf1G1_S1k80130_head.
- NP522512.RApbGFfkTiUTW7n4zqZmFbTvu6kLHAjh58qf1G1_S1k80130_assertion description "[Neutrophils from people with poorly controlled diabetes and in vitro incubation of neutrophils with high glucose and the receptor for advanced glycation end products ligand S100B greatly enhanced superoxide generation compared with controls, and this was significantly inhibited by BEL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP522512.RApbGFfkTiUTW7n4zqZmFbTvu6kLHAjh58qf1G1_S1k80130_provenance.
- NP522512.RApbGFfkTiUTW7n4zqZmFbTvu6kLHAjh58qf1G1_S1k80130_assertion evidence source_evidence_literature NP522512.RApbGFfkTiUTW7n4zqZmFbTvu6kLHAjh58qf1G1_S1k80130_provenance.
- NP522512.RApbGFfkTiUTW7n4zqZmFbTvu6kLHAjh58qf1G1_S1k80130_assertion SIO_000772 20053941 NP522512.RApbGFfkTiUTW7n4zqZmFbTvu6kLHAjh58qf1G1_S1k80130_provenance.
- NP522512.RApbGFfkTiUTW7n4zqZmFbTvu6kLHAjh58qf1G1_S1k80130_assertion wasDerivedFrom befree-20140225 NP522512.RApbGFfkTiUTW7n4zqZmFbTvu6kLHAjh58qf1G1_S1k80130_provenance.
- NP522512.RApbGFfkTiUTW7n4zqZmFbTvu6kLHAjh58qf1G1_S1k80130_assertion wasGeneratedBy ECO_0000203 NP522512.RApbGFfkTiUTW7n4zqZmFbTvu6kLHAjh58qf1G1_S1k80130_provenance.